Stories

Vaccine technology developed by OHSU scientists acquired by industry leaders

Vaccine technology developed by OHSU scientists acquired by industry leaders

By Ariane Le Chevallier January 25, 2017
A first-of-its-kind vaccine technology platform developed by renowned scientists at OHSU in Portland, Oregon, has been acquired by Vir Biotechnology, a San Francisco-based biotech startup backed by leading industry investor ARCH Venture Partners and the Bill & Melinda Gates Foundation, a leading funder of global health initiatives.
Doernbecher Freestyle: 13 years of kicks, more than $16.5 million raised

Doernbecher Freestyle: 13 years of kicks, more than $16.5 million raised

By Tracy Brawley January 24, 2017
Since 2004, 78 kids from across Oregon and Southwest Washington have participated in Doernbecher Freestyle, a one-of-a-kind fundraiser that pairs OHSU Doernbecher patients with Nike designers to create unique shoe and apparel collections that are auctioned and sold at retail, with 100 percent of the proceeds benefiting the children’s hospital.
Cancer survivor thanks her caregivers with a song

Cancer survivor thanks her caregivers with a song

By Amanda Gibbs January 23, 2017
Suse Skinner, 70, is fighting her second battle with cancer. In 2005 she was diagnosed with breast cancer, then in August 2016 she was admitted to OHSU for her first induction chemotherapy session for acute myeloid leukemia, where she underwent 24/7 chemotherapy for six days followed by six weeks of recovery.
OHSU announces 2017 Brain Awareness lecture series

OHSU announces 2017 Brain Awareness lecture series

January 23, 2017
This season's OHSU Brain Awareness lecture series will explore what happens with the brain when we’re not fully conscious, including moral choices, the effects of physical touch and vivid dreams.   WHEN: 7 p.m. Monday, March 20; Monday, March 27; and Tuesday, April 4    WHERE: Newmark Theatre, 1111 S.W. Broadway, Portland    DETAILS: This season’s lectures will explore what happens...
See more stories